231 related articles for article (PubMed ID: 36267414)
1. Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy.
Li Y; Zhang W; Dai Y; Chen K
Front Genet; 2022; 13():986995. PubMed ID: 36267414
[No Abstract] [Full Text] [Related]
2. Bioinformatics and Immune Infiltration Analyses Reveal the Key Pathway and Immune Cells in the Pathogenesis of Hypertrophic Cardiomyopathy.
Zhang XZ; Zhang S; Tang TT; Cheng X
Front Cardiovasc Med; 2021; 8():696321. PubMed ID: 34497835
[No Abstract] [Full Text] [Related]
3. Identification of the Immune Status of Hypertrophic Cardiomyopathy by Integrated Analysis of Bulk- and Single-Cell RNA Sequencing Data.
Zhao W; Wu T; Zhan J; Dong Z
Comput Math Methods Med; 2022; 2022():7153491. PubMed ID: 36238494
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of m6A/m7G/m5C/m1A-related gene expression and immune infiltration in liver ischemia-reperfusion injury by integrating bioinformatics and machine learning algorithms.
Meng Z; Li X; Lu S; Hua Y; Yin B; Qian B; Li Z; Zhou Y; Sergeeva I; Fu Y; Ma Y
Eur J Med Res; 2024 Jun; 29(1):326. PubMed ID: 38867322
[TBL] [Abstract][Full Text] [Related]
5. Identification of Potential Diagnostic Biomarkers and Biological Pathways in Hypertrophic Cardiomyopathy Based on Bioinformatics Analysis.
Yu T; Huang Z; Pu Z
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328083
[TBL] [Abstract][Full Text] [Related]
6. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.
Yin F; Liu K; Peng W; Jiang D; Zhang H; Guo P; Wu Y; Zhang X; Sun C; Wang Y; Wang H; Han Y
Oxid Med Cell Longev; 2023; 2023():3918393. PubMed ID: 36819785
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, clustering, and immune cell infiltration analysis of m6A-related genes in patients with acute myocardial infarction-a bioinformatics analysis.
Liang C; Wang S; Zhang M; Li T
J Thorac Dis; 2022 May; 14(5):1607-1619. PubMed ID: 35693610
[TBL] [Abstract][Full Text] [Related]
8. Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification.
Xu X; Shen L; Qu Y; Li D; Zhao X; Wei H; Yue S
Sci Rep; 2024 Apr; 14(1):8417. PubMed ID: 38600232
[TBL] [Abstract][Full Text] [Related]
9. Identification and verification of promising diagnostic biomarkers in patients with hypertrophic cardiomyopathy associate with immune cell infiltration characteristics.
Zheng X; Yang Y; Huang Fu C; Huang R
Life Sci; 2021 Nov; 285():119956. PubMed ID: 34520765
[TBL] [Abstract][Full Text] [Related]
10. Identification and Verification of Feature Immune-Related Genes in Patients With Hypertrophic Cardiomyopathy Based on Bioinformatics Analyses.
Zheng X; Liu G; Huang R
Front Cardiovasc Med; 2021; 8():752559. PubMed ID: 34765659
[No Abstract] [Full Text] [Related]
11. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
[TBL] [Abstract][Full Text] [Related]
12. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy.
Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ
Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267
[TBL] [Abstract][Full Text] [Related]
13. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
14. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y
Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069
[TBL] [Abstract][Full Text] [Related]
15. Prediction of diagnostic gene biomarkers for hypertrophic cardiomyopathy by integrated machine learning.
You H; Dong M
J Int Med Res; 2023 Nov; 51(11):3000605231213781. PubMed ID: 38006610
[TBL] [Abstract][Full Text] [Related]
16. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
Ma J; Yang D; Ma XX
Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
[TBL] [Abstract][Full Text] [Related]
17. Role of the N6-methyladenosine regulatory factor in reducing the risk of cardiovascular disease: subtype diagnosis following aerobic exercise-assisted weight loss.
Hao X; Li Y; Huang G; Zeng Y
Am J Transl Res; 2022; 14(8):5363-5378. PubMed ID: 36105062
[TBL] [Abstract][Full Text] [Related]
18. Machine learning-driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy.
Liu S; Yuan P; Zheng Y; Guo C; Ren Y; Weng S; Zhang Y; Liu L; Xing Z; Wang L; Han X
ESC Heart Fail; 2024 Apr; ():. PubMed ID: 38629342
[TBL] [Abstract][Full Text] [Related]
19. Novel insight into m6A regulator-mediated methylation modification patterns and immune characteristics in intracranial aneurysm.
Li S; Zhang Q; Weng L; Han Y; Li J
Front Aging Neurosci; 2022; 14():973258. PubMed ID: 36034129
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine modulation classes and immune microenvironment regulation in ischemic stroke.
Tao H; Dong L; Li L
Front Mol Neurosci; 2022; 15():1013076. PubMed ID: 36762188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
